Demand for hand transplants low due to cost, need for drugs

12/11/2012 | Philadelphia Inquirer, The

So few patients have taken advantage of advances in hand transplantation technology that some medical centers have yet to perform their first procedure two years after launching programs. Costs, patient selection criteria and the prospect of lifelong treatment with immunosuppressants deter possible candidates, experts say. Researchers are seeking ways to prevent organ rejection that use fewer drugs.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA